Does HUMALOG LISPRO Cause Glycosylated haemoglobin increased? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Glycosylated haemoglobin increased have been filed in association with HUMALOG LISPRO. This represents 3.2% of all adverse event reports for HUMALOG LISPRO.
14
Reports of Glycosylated haemoglobin increased with HUMALOG LISPRO
3.2%
of all HUMALOG LISPRO reports
0
Deaths
8
Hospitalizations
How Dangerous Is Glycosylated haemoglobin increased From HUMALOG LISPRO?
Of the 14 reports, 8 (57.1%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Glycosylated haemoglobin increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HUMALOG LISPRO. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does HUMALOG LISPRO Cause?
Blood glucose increased (172)
Blood glucose decreased (46)
Diabetic ketoacidosis (46)
Drug ineffective (29)
Malaise (28)
Hypoglycaemia (25)
Fall (23)
Blindness (19)
Incorrect dose administered (19)
Drug dose omission (18)
What Other Drugs Cause Glycosylated haemoglobin increased?
DULAGLUTIDE (2,691)
INSULIN GLARGINE (2,649)
INSULIN LISPRO (2,482)
METFORMIN (1,539)
INSULIN HUMAN (1,008)
EXENATIDE (921)
SEMAGLUTIDE (818)
EMPAGLIFLOZIN (743)
TIRZEPATIDE (555)
INSULIN ASPART (550)
Which HUMALOG LISPRO Alternatives Have Lower Glycosylated haemoglobin increased Risk?
HUMALOG LISPRO vs HUMALOG LISPRO, NPL
HUMALOG LISPRO vs HUMAN C1-ESTERASE INHIBITOR
HUMALOG LISPRO vs HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX
HUMALOG LISPRO vs HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
HUMALOG LISPRO vs HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN